Skin Pigmentation represents the major natural protection against the deleterious effects of Ultraviolet light and involves a crosstalk between keratinocytes and melanocytes. Pigment synthesis or melanogenesis is initiated by the binding of \(\alpha\)-Melanocyte Stimulating Hormone \((\alpha-MSH)\) to the Melanocortin 1 Receptor (MC1R), expressed by the melanocytes. α-MSH is generated by cleavage of pro-opiomelanocortin hormone (POMC), produced by both melanocytes and keratinocytes. Activation of MC1R leads to an increase in cAMP levels, causing the expression of the transcription factor MITF. MITF regulates the expression of the enzymes involved in melanogenesis as well as genes important for the survival and proliferation of melanocytes. Pigment synthesis, which occurs in specialized organelles called melanosomes, involves the regulation of different proteins as well as fine homeostatic tuning such as melanosomal pH regulation. The POMC derivative, \(\alpha-MSH\), begins the pigmentation pathway by activating the MC1R signaling pathway, and OCA2 regulates the end of this pathway by controlling tyrosinase activity. The OCA2 gene has been shown to be important in the control of intra-melanosomal pH to allow optimal conditions for the activity of Tyrosinase, the limiting enzyme of pigment (melanin) production. OCA2 polymorphisms have been linked to oculocutaneous albinism type 2 and to blue eye color, demonstrating the importance of this gene in fine pH regulation on pigment production. Polymorphisms in POMC have also been linked to red-haired/fair-skin color in humans. Despite the effort to dissect the mechanisms involved in the control of pigmentation, the transcriptional regulation of POMC and OCA2 are still not fully understood. In this study, we investigate the relevance of the cAMP/CREB pathway in the transcriptional regulation of these two proteins. Our data shows that both POMC and OCA2 expression increases after stimulation of the cAMP/CREB pathway. We demonstrate that MITF transcriptionally regulates OCA2: the cAMP/CREB pathway therefore induces OCA2 in a MITF-dependent manner. On the other hand, our data reveals that POMC may be regulated by cAMP in a MITF-independent fashion but consistent with the hypothesis of a positive feedback loop within the MC1R signaling pathway.

The Proopiomelanocortin gene, (POMC), produces many biologically active peptides including the endogenous opioid, β-endorphin, and the melanocortins: α-Melanocyte Stimulating Hormone, (αMSH), γMSH, βMSH and Adrenocorticotropic Hormone, (ACTH). βendorphin is released by the brain in response to stress or injury and is a potent analgesic. Melanocortins are well known for regulating pigmentation, metabolism, and cortisol levels. Additionally, opioids and melanocortins are known to have opposing actions in several settings including the regulation of pain and metabolism. The Melanocyte Stimulating Hormones are expressed in the skin where they bind the Melanocortin 1 Receptor on melanocytes and promote pigmentation. It has been reported that β-endorphin is also produced in the skin, however it was not believed to have a central effect. In this thesis I show that expression of these peptides in the skin is reflected in blood levels and affects nociception and behavior.

O ACTH é considerado o principal fator atuante no desenvolvimento, na manutenção e na esteroidogênese da glândula adrenal. No entanto, existem evidências que peptídeos N-Pomc, derivados do processamento da Proopiomelanocortina (POMC), possam atuar na manutenção do córtex adrenal, embora ainda não seja conhecida sua importância e mesmo quais são os peptídeos que atuam na suprarrenal. Nesse trabalho tivemos como objetivo avaliar os efeitos de peptídeos sintéticos de 28 aminoácidos derivados do N-Pomc (N-PomcCys, N-PomcMet e N-PomcSer) na morfologia e função da suprarrenal de camundongos, cujo gene Pomc foi condicionalmente silenciado com Tamoxifeno (Tmx). Foram obtidos animais machos adultos (CrePomcfloxflox) com um sistema \"knock-out\" condicional Cre-Lox induzível por Tmx, que foram tratados através de minibombas osmóticas por 21 dias com os peptídeos ou com salina, e como controle animais Pomcfloxflox não tratados. Foram analisados: 1) dados metabólicos; 2) a concentração de ACTH e de corticosterona plasmáticos; 3) a morfologia e a reconstrução anatômica da adrenal; 4) a capacidade funcional através da coloração com Oil Red O (ORO) e 5) a capacidade de proliferação através da expressão da proteína PCNA. A caracterização dos animais CrePomcfloxflox + Tmx após o silenciamento mostrou a redução de 60% da concentração de ACTH plasmático e esses animais apresentaram 1) redução do gasto energético, aumento da ingestão de alimentos e ganho de peso corpóreo; 2) alteração significante a área ou o volume das adrenais; 3) redução da produção de gotículas lipídicas e 4) redução do número de núcleos positivos para a proteína PCNA. Esses animais silenciados para a Pomc e tratados com os peptídeos N POMCCys e N-POMCMet apresentaram 1) aumento da corticosterona plasmática e apenas o N-POMCCys aumentou o ACTH plasmático; 2) aumento de núcleos marcados para PCNA. Concluímos, que os camundongos Cre Pomcflox/flox silenciados para a Pomc com o Tamoxifeno apresentaram alterações metabólicas, morfológicas e fisiológicas. A análise do efeito biológico dos peptídeos N-POMC mostrou ação desses peptídeos na função e na manutenção do córtex adrenal. / ACTH is considered the main active factor in the development, maintenance and steroidogenesis of the adrenal gland. However, there is evidence that N-Pomc peptides, derived from the processing of Proopiomelanocortina (POMC), may play a role in the maintenance of the adrenal cortex, although their importance is not yet known. In this work we aimed to evaluate the effects of synthetic peptides of 28 amino acids derived from N-Pomc (N-PomcCys, N-PomcMet e N-PomcSer) on the morphology and function of the adrenal cortex of mice whose Pomc gene was conditionally silenced with Tamoxifen (Tmx). Adult males (CrePomcfloxflox) were obtained with a Tmx inducible Cre-Lox conditional knock-out system, which were treated by osmotic minipumps for 21 days with the peptides or with saline, and as control untreated Pomcfloxfloxanimals. We analyzed: 1) metabolic data; 2) plasma ACTH and corticosterone concentration; 3) the morphology and the anatomical reconstruction of the adrenal; 4) functional capacity through staining with Oil Red O (ORO) and 5) the ability to proliferate through expression of PCNA protein. The characterization of the CrePomcfloxflox + Tmx animals after silencing showed a 60% reduction in plasma ACTH concentration and these animals presented 1) reduction of energy expenditure, increased food intake and body weight gain; 2) significant alteration of adrenal area or volume; 3) reduction of the production of lipid droplets and 4) reduction of the number of nuclei positive for the PCNA protein. These animals that were silenced to Pomc and treated with peptides N-PomcCys, N-PomcMet had 1) increase in plasma corticosterone and only N-POMCCys increased plasma ACTH; 2) increase of nuclei marked for PCNA. We conclude that CrePomcflox/flox mice silenced for Pomc with Tamoxifen presented metabolic, morphological and physiological alterations. The analysis of the biological effect of N-POMC peptides showed the action of these peptides on the function and maintenance of the adrenal cortex.

La reproduction est intimement liée à la balance énergétique, particulièrement chez les espèces sauvages exposées à des variations larges de leur environnement. L’objectif de cette thèse était d’étudier les mécanismes centraux qui régissent la régulation saisonnière de ces deux fonctions chez la gerboise. Nos résultats montrent une augmentation coordonnée au printemps de l’expression des gènes codant pour les neuropeptides impliqués dans la régulation de la reproduction et de la prise alimentaire, et rapportent des effets opposés de deux peptides classiquement considérés comme régulant la reproduction, Kisspeptine et RFRP-3, sur la prise alimentaire de la gerboise femelle ; un effet inhibiteur de Kisspeptine ayant lieu uniquement au printemps, et un effet activateur de RFRP-3 s’observant pendant les deux saisons. De plus, nous proposons que Kisspeptine et RFRP-3 exercent leurs effets sur la prise alimentaire via des actions sur des structures cérébrales dédiées au contrôle métabolique, notamment POMC et NPY. Dans l’ensemble, ces résultats renforcent notre hypothèse d’une coordination centrale de l’activité de la reproduction et de la prise alimentaire chez la gerboise et suggèrent une modulation de cette coordination en fonction du sexe et de l’environnement saisonnier. / Reproduction is intimately related to energy balance, especially in wild species exposed to marked seasonal changes in their environment. The aim of this thesis was to study the central mechanisms governing the seasonal regulation of these two functions in the jerboa. Our results reveal a spring coordinated increase in the expression of genes encoding neuropeptides involved in the regulation of reproduction and food intake, and report opposite effects of two central regulators of reproduction, Kisspeptin and RFRP-3, on food intake in the female jerboa; an inhibitory effect of Kisspeptin that occurs only in spring, and activatory effect of RFRP-3 observed in both seasons. Moreover, we propose that Kisspeptin and RFRP-3 display their effects on food intake via actions on brain structures dedicated to metabolic regulation, mainly POMC and NPY. Overall, these results strengthen our hypothesis of a central coordination of the jerboa’s reproductive activity and food intake and suggest a modulation of this coordination that depends on sex and seasonal environment.

L’hypothalamus est une structure cérébrale ayant un rôle clé dans la régulation de la prise alimentaire. Parmi les différentes populations neuronales qui le composent, les neurones produisant la pro-opiomélanocortine (POMC) sont classiquement connus pour diminuer la prise alimentaire et le poids corporel via la libération de neuropeptides produits par le clivage de POMC. Notre étude, grâce à l’utilisation d’approches génétiques, pharmacologiques, électrophysiologiques et moléculaires, remet en question les notions classiques sur la fonction des neurones à POMC dans la balance énergétique, en démontrant qu’il existe deux sous-populations fonctionnellement distinctes de neurones à POMC, qui augmentent ou diminuent la prise alimentaire en fonction du neurotransmetteur qu’elles libèrent, l’acide γ-aminobutyrique (GABA) ou le glutamate. Une troisième population capable de produire aussi bien du GABA que du glutamate a également été identifiée. La régulation des neurones à POMC GABAergiques et glutamatergiques dépend de la voie de la cible de la rapamycine chez les mammifères (mTORC1), qui fonctionne comme un détecteur d’énergie cellulaire, et du système endocannabinoïde (ECS), qui régule la libération de neurotransmetteurs. De plus, nous avons également démontré, via l’utilisation de souris mutantes conditionnelles, l’importance de la protéine p62 ou séquestrome 1 (p62/SQSTM1), qui régule l’activité de mTORC1 et l’autophagie, dans les neurones à POMC dans la régulation de l’homéostasie énergétique. Nos données offrent un nouvel aperçu sur les mécanismes moléculaires impliqués dans la régulation de la balance énergétique. / The hypothalamus is a brain structure with a key role in the regulation of food intake. Among the different neuronal populations of which it is composed, pro-opiomelanocortin (POMC) neurons are classically known to decrease food intake and body weight through the release of neuropeptides produced by the cleavage of POMC. Our study, through the use of genetic, pharmacological, electrophysiological and molecular approaches, challenges conventional notions about POMC neuron function in energy balance by showing that there are two functionally distinct POMC neuronal sub-populations, which increase or decrease food intake depending on which neurotransmitter they release, γ-aminobutyric acid (GABA) or glutamate. A third population capable of producing both GABA and glutamate has also been identified. The regulation of POMC GABAergic and glutamatergic neurons depends on the mechanistic target of rapamycin complex 1 (mTORC1) pathway, which functions as a cellular energy sensor, and the endocannabinoid system (ECS), which regulates neurotransmitters release. In addition, we have also demonstrated through the use of a conditional knockout mice, the importance of the protein p62 or sequestrome 1 (p62/SQSTM1), which regulates mTORC1 activity and autophagy, in POMC neurons for the regulation of energy homeostasis. Our data provide new insights on the molecular mechanisms involved in the regulation of energy balance.

<p>This thesis shows that socially subordinate Arctic charr (<i>Salvelinus alpinus</i>) display elevated brain serotonergic (5-HT) and norepinephric activity along with a chronic activation of the hypothalamic-pituitary-interrenal (HPI) axis, including elevated plasma concentrations of á-MSH. Furthermore, subordinate fish showed an inhibition of aggressive behaviour and darker body coloration, skin darkness being positively correlated with plasma á-MSH. Fish kept on dark background, and thus being darker in body colour, were less aggressive than conspecifics interacting on white background, supporting the hypothesis that skin darkening could signal social submission. The 5-HT_1A-receptor agonist 8-OH-DPAT stimulated HPI axis activity in non-stressed fish, but if administrated to stressed fish it inhibited HPI axis activity, suggesting that 5-HT_1A receptors may act as both post- and pre-synaptic receptors. 8-OH-DPAT also induced skin darkening in both non-stressed and stressed fish. Stimulation of brain dopaminergic activity by L-dopa treatment counteracted the stress-induced inhibition of aggressive behaviour, and stress related effects on brain 5-HT activity and plasma levels of cortisol. In conclusion, social subordination in Arctic charr results in skin darkening and an inhibition of aggressive behaviour. Stress-induced effects, that could be mediated by elevated brain 5-HT activity, and serve as a way of signalling social position and coping with stress.</p>

This thesis shows that socially subordinate Arctic charr (Salvelinus alpinus) display elevated brain serotonergic (5-HT) and norepinephric activity along with a chronic activation of the hypothalamic-pituitary-interrenal (HPI) axis, including elevated plasma concentrations of á-MSH. Furthermore, subordinate fish showed an inhibition of aggressive behaviour and darker body coloration, skin darkness being positively correlated with plasma á-MSH. Fish kept on dark background, and thus being darker in body colour, were less aggressive than conspecifics interacting on white background, supporting the hypothesis that skin darkening could signal social submission. The 5-HT1A -receptor agonist 8-OH-DPAT stimulated HPI axis activity in non-stressed fish, but if administrated to stressed fish it inhibited HPI axis activity, suggesting that 5-HT1A receptors may act as both post- and pre-synaptic receptors. 8-OH-DPAT also induced skin darkening in both non-stressed and stressed fish. Stimulation of brain dopaminergic activity by L-dopa treatment counteracted the stress-induced inhibition of aggressive behaviour, and stress related effects on brain 5-HT activity and plasma levels of cortisol. In conclusion, social subordination in Arctic charr results in skin darkening and an inhibition of aggressive behaviour. Stress-induced effects, that could be mediated by elevated brain 5-HT activity, and serve as a way of signalling social position and coping with stress.

Proopiomelanocortin (POMC) is a polypeptide precursor with 241 amino acid residues which undergoes extensive post-translational modification to yield a range of smaller, biological active peptides including £\-, £] -, £^-melanocyte-stimulating hormone (£\-MSH, £]-MSH, £^-MSH )¡A£]-endorphin (£]-EP) and adrenocorticotrophic hormone (ACTH). POMC-derived peptides play important roles in appetite and energy homeostasis. Recently, the peripheral POMC system is under active investigation to delineate their pathogenic roles in metabolic diseases such as Cushing¡¦s syndrome and obesity. In the present study, we utilized adenovirus gene delivery system to achieve systemic POMC overexpression in adult C57/BL6 mice for at least 30 days. Subsequently, the plasma and abdominal adipose tissue of mice were collected and analyzed by biochemical assays and weight determination respectively. POMC overexpression did not increase in the food uptake and body weight. These results imply that local POMC gene delivery induced the visceral fat accumulation and altered the metabolism in mice. It was observed that systemic POMC overexpression significantly elevated the triglyceride and the cholesterol levels in mice. However, POMC gene delivery also induced elevated plasma glucose concentration at weeks 1-4 and evoked glucose tolerance in mice at week 4. Interestingly, insulin resistance was readily detected in POMC-transduced in mice at as early as week 1. Besides, Micro-CT scanning and histological studies demonstrated that the visceral fat was significantly increased in POMC over-expressing mice compared with control animals. These data indicate that hepatic POMC gene delivery causes systemic ACTH rise and insulin resistance, which recapitulates the clinical features of Cushing¡¦s syndrome. In summary, POMC gene delivery induces systemic POMC overexpression and results in visceral fat accumulation and insulin resistance, which may facilitates a mice model for Cushing¡¦s-like metabolic syndrome.

Nutrient sensing neurons are unique in coupling changes in the concentration of nutrients to changes in neuronal activity. These neurons typically exist in regions of the brain where the blood brain barrier is fenestrated, such as the arcuate nucleus of the hypothalamus. Glucose and leucine are nutrients known to be sensed by neurons in this brain region, but the mechanisms by which they are sensed, and cells that sense them require further study. Using calcium imaging of adult neuron cultures from the mouse mediobasal hypothalamus, I demonstrated that leucine bidirectionally regulates neuronal activity in a neurochemically heterogeneous population of neurons, including AgRP/NPY and POMC neurons. Using pharmacological tools, I demonstrated, unexpectedly, that this acute sensing is independent of mTOR and leucine metabolism, known pathways involved in leucine sensing in vivo. Leucine sensing is LAT1 independent. The response principally relies on calcium entry into the cell across the plasma membrane, but IP3 sensitive calcium stores play a role in neurons inhibited by leucine. Using phosphoTRAP and single cell RNA sequencing, I aimed to identify a molecular marker for leucine sensing cells to allow their manipulation in vivo. PhosphoTRAP, and subsequent pharmacological studies identified a T Type calcium channel may be a marker for leucine sensing cells. AgRP neurons are essential for feeding, and also play roles in controlling glucose homeostasis. Using chemogenetics to selectively activate these neurons, I demonstrated, in contrast to a similar, recently published study, that blood glucose concentrations did not rise upon activation of these neurons. A subpopulation of AgRP neurons express glucokinase, and some AgRP neurons are glucose inhibited, but the role of glucokinase in these neurons has not been characterised. Our lab generated an AgRP neuron specific glucokinase knock out mouse line. Preliminary results suggest 18 – 25 week old female AgRP glucokinase knock out mice may have altered glucose tolerance, but conclusions can only be drawn once further mice have been phenotyped, and the success of the glucokinase knock out from AgRP neurons has been confirmed.

Indiana University-Purdue University Indianapolis (IUPUI) / Metabolic survival mechanisms that defend body weight and conserve energy are currently at odds with modernized society which has a food supply that is ubiquitous, calorie dense, and highly palatable. Chronic overnutrition leads to a metabolic syndrome of obesity, insulin resistance, inflammation, and cardiovascular diseases that is increasingly prevalent and threatens health on a global scale. The brain is both a victim and culprit of metabolic diseases, and prolonged metabolic dysfunction can exacerbate the pathological mechanisms underlying both metabolic and neurodegenerative diseases. Since neuroendocrine pathways comprise an essential feedback mechanism that detects circulating hormones and nutrients in order to regulate satiety, energy expenditure, and glucose homeostasis, our research goals were to characterize molecular mechanisms within neuroendocrine pathways that could be leveraged for treating obesity, diabetes, and Alzheimer’s disease. First, we identified the expression of a G protein-coupled receptor, Gpr17, in POMC neurons and discovered that it protects aged mice from high-fat diet (HFD)-induced metabolic derangements. We examined the electrophysiological properties of POMC neurons and found Gpr17 deficiency led to increased spontaneous action potentials. Moreover, Pomc-Cre-driven Gpr17 knockout (PGKO) mice, especially female knockouts, had increased POMC-derived alpha-melanocyte stimulating hormone and beta-endorphin despite a comparable level of prohormone POMC in their hypothalamic extracts. Second, we generated a highly insulin resistant mouse model with human GLUT4 promoter-driven insulin receptor knockout (GIRKO) in muscle, adipose, and GLUT4-expressing neuronal subpopulations. This genetic approach recapitulates the primary defect preceding type 2 diabetes (T2D) and revealed additional factors/mechanisms that drive the ultimate progression of overt diabetes. Third, we used 5xFAD mice as a model of Alzheimer’s disease and showed that they were more susceptible to HFD-induced metabolic dysregulation and expression of AD pathological markers in the hippocampus. Our results helped elucidate the molecular and cellular mechanisms responsible for increased AD pathology in high-fat diet-fed 5xFAD mice and suggest that metabolic dysfunctions are a therapeutic target to ameliorate AD pathology. In conclusion, metabolic diseases are pervasive and require nuanced approaches that target the neuroendocrine system in order to restore metabolic homeostasis and protect the brain from neurodegenerative processes that are associated with obesity and diabetes.